DENTSPLY SIRONA (NASDAQ:XRAY) Given New $38.00 Price Target at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective cut by investment analysts at Barrington Research from $41.00 to $38.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective suggests a potential upside of 34.32% from the company’s current price.

XRAY has been the topic of a number of other research reports. SVB Leerink assumed coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Leerink Partnrs reaffirmed an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Piper Sandler reissued a “neutral” rating and issued a $32.00 price objective (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Friday. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $36.90.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $28.29 on Friday. The stock has a 50-day simple moving average of $32.13 and a 200 day simple moving average of $32.71. The company has a current ratio of 1.43, a quick ratio of 0.95 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 52-week low of $26.27 and a 52-week high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.39 earnings per share. As a group, sell-side analysts forecast that DENTSPLY SIRONA will post 2.04 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in XRAY. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 1.5% during the 3rd quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock worth $862,555,000 after buying an additional 369,213 shares during the period. Nuance Investments LLC increased its position in DENTSPLY SIRONA by 30.4% during the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock worth $412,982,000 after acquiring an additional 2,702,457 shares during the period. First Eagle Investment Management LLC raised its stake in DENTSPLY SIRONA by 1.2% in the 4th quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock worth $348,314,000 after purchasing an additional 120,508 shares in the last quarter. Wellington Management Group LLP boosted its holdings in DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after purchasing an additional 1,419,503 shares during the period. Finally, Cooke & Bieler LP grew its position in shares of DENTSPLY SIRONA by 18.3% during the 4th quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock worth $251,333,000 after purchasing an additional 1,092,922 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.